ENGYS is pleased to announce its participation in the ROMed2VR project, aimed at improving pre-surgical planning for congenital heart defects through the integration of Computational Fluid Dynamics (CFD) and Virtual Reality (VR) technologies. This initiative seeks to develop a streamlined computational procedure that leverages open-source CFD and Reduced Order Models (ROM) to enhance the precision and effectiveness of Modified Blalock-Taussig Shunt procedures.
The project kicked off with a meeting held in Trieste, Italy, on 25 November 2024, where key objectives and collaborative strategies were outlined. ENGYS will contribute its expertise in open-source CFD solutions to support the development of the ROMed2VR system.
The consortium partners include RBF Morph, specialists in Reduced Order Models for CFD applications; InSilicoTrials Technologies, developers of digital platforms for medical and pharmaceutical simulations; and the BioCardioLab of “Fondazione Toscana Gabriele Monasterio,” a research institution focusing on cardiovascular innovations. Together, these organisations bring a diverse range of expertise to ensure the project’s success.
Project Details:
- Acronym: ROMed2VR
- Title: Virtual Reality Empowered by Computational Fluid Dynamics Reduced Order Models to Support Pre-Surgery Medical Planning
- Duration: 12 months (1 November 2024 to 31 October 2025)
- Total Cost: €426,644.42
- Total Funding: €319,010.23
By integrating advanced CFD simulations with VR, the ROMed2VR project aims to provide medical professionals with enhanced tools for planning and executing surgical interventions, ultimately improving patient outcomes.
